Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimme Hyrich

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Diagnostic and Prognostic Research|July 17, 2020
Harnessing repeated measurements of predictor variables for clinical risk prediction: a review of existing methodsLucy M Bull, Mark Lunt, Glen P Martin, et al.
Rheumatology (Oxford, England)|December 28, 2018
Gender stratified adjustment of the DAS28-CRP improves inter-score agreement with the DAS28-ESR in rheumatoid arthritisPhilip D H Hamann, Gavin Shaddick, Kimme Hyrich, et al.
Arthritis Care & Research|August 27, 2016
Factors Associated With Sustained Remission in Rheumatoid Arthritis in Patients Treated With Anti-Tumor Necrosis FactorPhilip Hamann, Richard Holland, Kimme Hyrich, et al.
British Journal of Health Psychology|October 10, 2017
The prioritization of symptom beliefs over illness beliefs: The development and validation of the Pain Perception Questionnaire for Young PeopleDaniela Ghio, Wendy Thomson, Rachel Calam, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 8, 2019
Profiling of Gene Expression Biomarkers as a Classifier of Methotrexate Nonresponse in Patients With Rheumatoid ArthritisDarren Plant, Mateusz Maciejewski, Samantha Smith, et al.
American Journal of Epidemiology|January 21, 2009
Different methods of balancing covariates leading to different effect estimates in the presence of effect modificationMark Lunt, Daniel Solomon, Kenneth Rothman, et al.
Rheumatology (Oxford, England)|January 19, 2017
The predictive value of serum S100A9 and response to etanercept is not confirmed in a large UK rheumatoid arthritis cohortSamantha Louise Smith, Darren Plant, Stephen Eyre, et al.
Arthritis Research & Therapy|December 16, 2015
Investigating CD11c expression as a potential genomic biomarker of response to TNF inhibitor biologics in whole blood rheumatoid arthritis samplesSamantha Louise Smith, Stephen Eyre, Annie Yarwood, et al.
Scientific Reports|April 1, 2021
Prediction of response of methotrexate in patients with rheumatoid arthritis using serum lipidomicsMateusz Maciejewski, Caroline Sands, Nisha Nair, et al.
Rheumatology (Oxford, England)|September 24, 2010
Detection and evaluation of a drug safety signal concerning pancreatic cancer: lessons from a joint approach of three European biologics registersAnja Strangfeld, Kimme Hyrich, Johan Askling, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Diagnostic and Prognostic Research|July 17, 2020
Harnessing repeated measurements of predictor variables for clinical risk prediction: a review of existing methodsLucy M Bull, Mark Lunt, Glen P Martin, et al.
Rheumatology (Oxford, England)|December 28, 2018
Gender stratified adjustment of the DAS28-CRP improves inter-score agreement with the DAS28-ESR in rheumatoid arthritisPhilip D H Hamann, Gavin Shaddick, Kimme Hyrich, et al.
Arthritis Care & Research|August 27, 2016
Factors Associated With Sustained Remission in Rheumatoid Arthritis in Patients Treated With Anti-Tumor Necrosis FactorPhilip Hamann, Richard Holland, Kimme Hyrich, et al.
British Journal of Health Psychology|October 10, 2017
The prioritization of symptom beliefs over illness beliefs: The development and validation of the Pain Perception Questionnaire for Young PeopleDaniela Ghio, Wendy Thomson, Rachel Calam, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 8, 2019
Profiling of Gene Expression Biomarkers as a Classifier of Methotrexate Nonresponse in Patients With Rheumatoid ArthritisDarren Plant, Mateusz Maciejewski, Samantha Smith, et al.
American Journal of Epidemiology|January 21, 2009
Different methods of balancing covariates leading to different effect estimates in the presence of effect modificationMark Lunt, Daniel Solomon, Kenneth Rothman, et al.
Rheumatology (Oxford, England)|January 19, 2017
The predictive value of serum S100A9 and response to etanercept is not confirmed in a large UK rheumatoid arthritis cohortSamantha Louise Smith, Darren Plant, Stephen Eyre, et al.
Arthritis Research & Therapy|December 16, 2015
Investigating CD11c expression as a potential genomic biomarker of response to TNF inhibitor biologics in whole blood rheumatoid arthritis samplesSamantha Louise Smith, Stephen Eyre, Annie Yarwood, et al.
Scientific Reports|April 1, 2021
Prediction of response of methotrexate in patients with rheumatoid arthritis using serum lipidomicsMateusz Maciejewski, Caroline Sands, Nisha Nair, et al.
Rheumatology (Oxford, England)|September 24, 2010
Detection and evaluation of a drug safety signal concerning pancreatic cancer: lessons from a joint approach of three European biologics registersAnja Strangfeld, Kimme Hyrich, Johan Askling, et al.
Pageof 5